DIRS.INFO The most relevant business & tech news

☆ Cyberattack on UnitedHealth firm forces doctors to dig into personal savings to stay afloat
▼ + stars: | 2024-04-30 | by ( Ashley Capoot | In | ) www.cnbc.com time to read: +19 min

Change Healthcare offers payment and revenue cycle management tools, and other solutions such as electronic prescription software. On Feb. 21, UnitedHealth Group , which owns Change Healthcare, discovered that hackers compromised part of the unit's information technology systems. UnitedHealth told CNBC earlier this month that there is "no evidence of any new cyber incident at Change Healthcare." It's just one of the ways Change Healthcare touches cash flow within the health-care sector. A controversial mergerSheldon Cooper | Sopa Images | Lightrocket | Getty ImagesUnitedHealth's ownership of Change Healthcare has raised eyebrows from the outset.

Persons: Omar Marques, Dr, Angeli Maun Akey, Akey, she's, UnitedHealth, I've, Andrew, Mike Bradley, Barbara McAneny, McAneny, Sarah Carlson, Carlson, Sheldon Cooper, Optum, Michael Nagle, Tyler Kisling, Kisling, he's, There's, it's, Purvi, Parikh hadn't, they've, Amit Phull, Phull, Igor Golovniov Organizations: Lightrocket, CNBC, Healthcare, UnitedHealth, U.S . Securities, Exchange Commission, Change, Inc, Bloomberg, Getty, U.S, American Medical Association, AMA, U.S . Department of Justice, DOJ, U.S . Department of Health, Human Services, Wall Street, New York Stock Exchange, Change Healthcare Locations: Gainesville , Florida, U.S, Minnetonka , Minnesota, UnitedHealth's, New Mexico, Boulder , Colorado, California, New York City, UnitedHealth

☆ A bearish options trade on this health care giant that's starting to show signs of cracking
▼ + stars: | 2024-04-23 | by ( Nishant Pant | ) www.cnbc.com time to read: +3 min

However, with broader market indicators showing signs of weakness, UNH is starting to reveal cracks — and the once-strong rally appears to be losing steam. The trade setup The trade structure I am using here is called a "bear put spread." Most trading platforms will offer a bear put spread (or long put spread) as a trade type and automatically construct the trade for you. Since the width of our spread is $495– $490 = $5, I can buy the spread for $2.50. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR.

Persons: UnitedHealth, UNH, ADX, Nishant Pant Organizations: Change, ½

☆ Final Trade: UNH, XLU, EXC, META
▼ + stars: | 2024-04-19 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFinal Trade: UNH, XLU, EXC, METAThe final trades of the day with CNBC’s Melissa Lee and the Fast Money traders.

Persons: CNBC’s Melissa Lee Organizations: Fast Money

☆ Goldman Sachs is strong, Netflix raises questions: What we learned from earnings this week
▼ + stars: | 2024-04-19 | by ( Hakyung Kim | ) www.cnbc.com time to read: +6 min

Of those companies, 73.6% have beaten earnings expectations, FactSet data shows. Investment banks doing well, BofA not so much The major banks that posted results this week — Goldman Sachs , Morgan Stanley and Bank of America — beat earnings expectations. Bank of America shares fell more than 3% despite the company beating on both top and bottom lines. Mixed earnings picture Although nearly three-quarters of the reported earnings so far have topped expectations, the broader earnings picture is more muddled. The blended earnings growth rate, which considers the reports already out and the estimates from those still pending, sits at just 0.16%.

Persons: — Goldman Sachs, Morgan Stanley, Alastair Borthwick, Wells, Mike Mayo, Goliath, Mayo, Goldman Sachs, Wells Fargo's Mayo, Goldman, Ebrahim Poonawala, cyberattack, George Hill, Doug Anmuth, Jessica Reif Ehrlich, Canaccord Genuity, Chris Harvey Organizations: Investment, Bank of America —, Bank of America, Bank of America's, JPMorgan, Wells, of America, Deutsche, Netflix, NFLX's, Revenue, Microsoft, Exxon Mobil

☆ Earnings playbook: Your guide to trading the biggest reports of the week, including Netflix and Goldman Sachs
▼ + stars: | 2024-04-14 | by ( Fred Imbert | ) www.cnbc.com time to read: +8 min

What history shows: Goldman Sachs beats earnings estimates 85% of the time, according to Bespoke Investment Group. What CNBC is watching: Bank of America shares have struggled lately, losing 5.6% this month as investors reprice rate cut expectations. Morgan Stanley is set to report earnings before the open. United Airlines is set to report earnings after the close. Thursday Netflix is set to report earnings after the close.

Persons: Goldman Sachs, Morgan Stanley, JPMorgan Chase, Goldman, Devin Ryan, Morgan, Ryan, UNH, UnitedHealth, LSEG, UAL, Leslie Josephs, Oppenheimer, Jason Helfstein, Procter & Gamble, Dara Mohsenian, Procter Organizations: Bank of America, Netflix, JPMorgan, CNBC, JMP Securities, Investment, Tuesday Bank of America, UBS, BofA, Dow Jones Industrial, Street, United Airlines, Boeing, Max, Federal Aviation Administration, San Francisco, United, Procter & Locations: Charlotte, San, U.S, China

☆ 3 of our stocks report earnings next week. Here's what we want to see from each
▼ + stars: | 2024-04-13 | by ( Zev Fima | ) www.cnbc.com time to read: +8 min

Heightened tensions in the Middle East, including the possibility of Iran attacking Israel, sent stocks back down and oil prices higher. If the choice is between a weak economy with lower rates or a strong economy with higher rates, we'll take the strong economy every time. Low rates may help with valuation multiples, but it's a strong economy that leads to earnings growth and that's what we, as long-term investors care about. Shelter costs are a major sticking point for overall inflation, which makes Tuesday's housing starts and building permits report a key watch item. We'll get another look at housing with the release of the March existing home sales report on Thursday.

Persons: we've, we'll, Morgan Stanley, Wells, bode, we're, Goldman Sachs, Charles Schwab, Johnson, ERIC, JB Hunt, Kinder Morgan, DR, Ally, Huntington, Jim Cramer's, Jim Cramer, Jim, Abbott, Ethan Miller Organizations: Dow Jones, Wednesday, Federal Reserve, Abbott Labs, Cardiovascular Systems, Diagnostics, Procter & Gamble, Constellation Brands, Procter, T Bank, Bank of America, Bank of New York Mellon, BK, PNC Financial, PNC, Ericsson, United Airlines, Interactive, ASML Holdings, US Bancorp, Citizens, Alcoa, CSX, Discover Financial, Nokia, Alaska Air, Blackstone BX, McLennan, Netflix, PPG Industries, Gamble, Financial, American Express, Jim Cramer's Charitable, CNBC, Las Vegas Convention, Getty Locations: Iran, Israel, China, Marsh, Las Vegas , Nevada

☆ Final Trade: TYL, UNH, SLB, AEM
▼ + stars: | 2024-04-05 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFinal Trade: TYL, UNH, SLB, AEMThe final trades of the day with CNBC’s Melissa Lee and the Fast Money traders.

Persons: CNBC’s Melissa Lee Organizations: Fast Money

☆ Comeback stories? These stocks have underperformed but are expected to do well
▼ + stars: | 2024-04-01 | by ( Hakyung Kim | ) www.cnbc.com time to read: +2 min

Multiple stocks are lagging the market this year, but Wall Street says don't write them off yet — they could soon be due for a turnaround. With this in mind, CNBC Pro screened for stocks in the S & P 500 that might be positioned for a rebound this year. Shares were down 2.3% in 2024 thru the open Wednesday March 27, but the average price target implies around 22% upside potential, according to FactSet. Match was also highlighted as one of Goldman Sachs' favorite asset-light stocks earlier this month. According to the consensus analyst price target, the stock could rise 20.1%, per FactSet.

Persons: financials, Goldman Sachs, Fred Imbert Organizations: CNBC Pro, UnitedHealth, Caesars Entertainment, LSEG, Lines

☆ Here are Wednesday's biggest analyst calls: Apple, Tesla, Nvidia, Super Micro, Honeywell, Target & more
▼ + stars: | 2024-03-06 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Wednesday's biggest calls on Wall Street: Berenberg upgrades Honeywell to buy from hold Berenberg said the industrial conglomerate is well positioned. Roth MKM initiates Aspen Aerogels as buy Roth said it sees a "strong secular opportunity" for the insulation company. HSBC upgrades Target to buy from neutral HSBC said it likes the company's strategy following earnings on Tuesday. " Target's strategy aims to drive long-term sales growth market share gains and improve profitability Deutsche Bank upgrades Target to buy from neutral Deutsche upgraded Target following earnings on Tuesday. Argus initiates Super Micro as buy Argus said it sees "years" of growth for shares of Super Micro.

Persons: Berenberg, Morgan Stanley, Tesla, Roth MKM, Roth, JPMorgan, Wolfe, Evercore, Needham, SMCI Organizations: Honeywell, Barclays, Aspen, HSBC, Target, Deutsche Bank, Deutsche, JPMorgan, BBB, Citi, Madrigal Pharmaceuticals, Motors, RBC, EV, ISI, Bank of America, Google, Apple, Nvidia, NVIDIA, Crinetics Pharmaceuticals, Argus, Super Locations: China, Dominion

☆ Stocks with high dividend growth and free cash flow perform best whatever the weather, Wolfe says
▼ + stars: | 2024-03-06 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +3 min

Stocks that offer high dividend growth and high free cash flow perform best no matter the economic weather, according to Wolfe Research. Here are a few stocks that fit the bill, according to Senyek: Online marketplace eBay was one of several stocks that Wolfe singled out. With its 4% yield, CVS is also a good buy for investors focusing on a high-dividend growth, high free cash flow strategy, Wolfe said. Following CVS' earnings release, investment bank Leerink initiated research coverage of the stock with an outperform rating , citing its cash potential. Other stocks Wolfe included on its list were Constellation Energy , Humana and Archer-Daniels-Midland .

Persons: Chris Senyek, Wolfe, UnitedHealth, Andrew Mok, Tom Cowhey, — CNBC's Michael Bloom Organizations: Wolfe Research, eBay, Barclays, Medicare, CVS, Constellation Energy, Humana, Archer, Daniels, Midland

Morgan Stanley cut its price target on Tesla after trimming its profitability forecasts. The analyst has a price target of $500, which implies upside of more than 20% over the next 12 months. — Hakyung Kim 6:51 a.m.: JPMorgan raises CrowdStrike price target after earnings beat CrowdStrike is managing to grow quickly while delivering strong results, says JPMorgan. The bank upgraded the retailer to buy from hold, increasing its price target to $195 from $140. — Fred Imbert 5:40 a.m.: Morgan Stanley cuts Tesla price target 2024 will be for electric vehicles, said Morgan Stanley's Adam Jonas, who warns that Tesla could lose money this year.

Persons: Morgan Stanley, Wells, Andrew Nowinski, MongoDB, Hakyung Kim, CrowdStrike, Brian Essex, Essex, — Hakyung Kim, UnitedHealth, Andrew Mok, Mok, Berenberg, Philip Buller, Buller, Bob Jian Huang, Huang, Daniela Bretthauer, Krisztina Katai, — Fred Imbert, Morgan Stanley's Adam Jonas, Tesla, Jonas Organizations: CNBC, HSBC, Target, JPMorgan, Barclays, Medicare, Honeywell, Berenberg, Morgan Stanley Insurance, Progressive, Target . Deutsche Bank Locations: Andrew Mok ., Honeywell's, U.S, Tuesday's

☆ CNN Poll: Trump’s lead over Haley widens to double digits in New Hampshire
▼ + stars: | 2024-01-21 | by ( Jennifer Agiesta | ) edition.cnn.com time to read: +10 min

CNN —The race for the New Hampshire Republican presidential primary appears to be former President Donald Trump’s to lose, according to a new CNN poll conducted by the University of New Hampshire following Trump’s 30-point win in Iowa’s caucuses last week. Trump holds 50% support among likely Republican primary voters in the Granite State, while his closest competitor, former South Carolina Gov. Likely Republican and Democratic primary voters were identified through survey questions about their intention to vote. Results among 1,210 likely Republican primary voters have an error margin of plus or minus 2.8 percentage points. Results among 838 likely Democratic primary voters have an error margin of plus or minus 3.5 percentage points.

Persons: Donald Trump’s, Trump, Nikki Haley, Haley, Ron DeSantis, DeSantis, “, Joe Biden, Biden, ” Biden, Dean Phillips, Marianne Williamson, Phillips, Biden hasn’t Organizations: CNN, New Hampshire Republican, University of New, Republican, South Carolina Gov, Trump, Florida Gov, GOP, Democratic, Biden, Democratic National, Minnesota, CNN New, University of New Hampshire Survey Locations: University of New Hampshire, Granite State, New Hampshire, Trump, Mexico, Russia, Ukraine, CNN New Hampshire, Hampshire

☆ Why we like health-care stocks in 2024 despite their spotty record in presidential election years
▼ + stars: | 2024-01-18 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +11 min

The S & P 500 Health Care Sector index has outperformed the broader S & P 500 in just three of the past eight presidential election years dating back to 1992, according to FactSet data. So far in 2024, health care has been the best-performing sector in the S & P 500, climbing roughly 2%. .GSPHC .SPX YTD mountain Health care sector vs. S & P 500 YTD It's way too early for any grand predictions with Election Day 2024 about 10 months away. Nevertheless, we see attractive fundamentals in the year ahead for a host of health-care stocks, giving us the confidence to own Lilly, GE Healthcare and Danaher despite what history says about the group in presidential election years. After a strong 2022 for health care in a terrible overall market, investors last year placed a lower emphasis on the defensive characteristics of health care.

Persons: —, that's, Eli Lilly, Lilly, Jim Cramer, Jim, Sen, Bernie Sanders of, Joe Biden, Sanders, would've, Damien Conover, Conover, Biden, Eli Lilly's, Morningstar, Amgen, Morningstar's Conover, Lilly's donanemab, Humana, Bausch, Jim Cramer's, Frederick Florin Organizations: Health, GE Healthcare, Abbott Laboratories, Amgen, Novartis, Walgreens Boots Alliance, JPMorgan Healthcare Conference, Democratic, Morningstar, CNBC, Horizon Therapeutics, Novo Nordisk, Federal Reserve, General Electric, Medicare, Humana, UnitedHealth Group, Investors, AFP, Getty Locations: San Francisco, U.S, Bernie Sanders of Vermont, Canadian, Fegersheim, France

☆ Earnings playbook: Your guide to the biggest reports this week, including JPMorgan
▼ + stars: | 2024-01-07 | by ( Fred Imbert | ) www.cnbc.com time to read: +6 min

Friday UnitedHealth is set to report earnings before the bell, with a conference call scheduled for 8:45 a.m. JPMorgan Chase is set to report earnings before the market opens. Management has said it will disclose severance costs and job cuts along with fourth quarter earnings." Delta Air Lines is set to report earnings before the bell, followed by a call at 10 a.m. What history shows: Bank of America beats earnings estimates 79% of the time, per Bespoke.

Persons: Wells, John Butters, Butters, UNH, UnitedHealth, CVS, JPMorgan Chase, Hugh Son, Jane, DAL, Leslie Josephs Organizations: JPMorgan Chase, Citigroup, Bank of America, Delta Airlines, CNBC, LSEG, JPMorgan, First, Management, Delta Air Lines, CNBC CNBC, Delta Locations: Wells Fargo

Dec 5 (Reuters) - Eli Lilly (LLY.N) on Tuesday said its recently approved obesity treatment Zepbound is now available in U.S. pharmacies and could cost $550 a month for customers whose health insurance does not cover the drug, or half the list price. Wall Street analysts expect sales of Zepbound to reach about $2 billion in 2024, and for sales of Novo Nordisk's (NOVOb.CO) rival obesity drug Wegovy to hit around $7.5 billion. An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. When the U.S. Food and Drug Administration approved Zepbound in November, Lilly said it would launch after the U.S. Thanksgiving holiday. Lilly's obesity drug has the same active ingredient, tirzepatide, as its previously approved diabetes drug Mounjaro, which has been used off-label for weight loss since its 2022 launch.

Persons: Eli Lilly, Wegovy, danuglipron, Zepbound, Lilly, Mike Segar, Eli Lilly's, Patrick Wingrove, Manas Mishra, Khushi, Arun Koyyur, Alexander Smith, Bill Berkrot Organizations: Wall Street, Novo, Pfizer, Company, REUTERS, CVS, U.S . Food, Drug Administration, U.S, Thomson Locations: U.S, Branchburg , New Jersey, Indianapolis, New York, Bengaluru

REUTERS/Andrew Kelly/File Photo Acquire Licensing RightsNov 29 (Reuters) - Cigna (CI.N) and Humana (HUM.N), two of the biggest U.S. health insurers, are in talks for what could be the largest merger announced in 2023, according to a source familiar with the matter. A Humana and Cigna combination would give the merged company the scale to rival UnitedHealth Group (UNH.N) and CVS Health (CVS.N). In July 2016, the Justice Department filed lawsuits against two health insurance mergers on the same day, saying they would lead to less competition and higher prices for Americans. Health insurers have been facing higher medical costs as people return for procedures they had put off during the pandemic. Humana in February said that it would sell its commercial business but keep its Medicare Advantage products.

Persons: Andrew Kelly, Cigna, Cigna's, Aetna, Bill Baer, Andre Barlow of Doyle, Barlow, Mazard, Bernstein, Lance Wilkes, Craig Garthwaite, Manas Mishra, Diane Bartz, Deena Beasley, Caroline Humer, Bill Berkrot Organizations: Humana Inc, REUTERS, Street Journal, UnitedHealth, CVS Health, Humana’s, Medicare, Affordable, Justice Department, Humana, U.S ., Reuters, Northwestern University, Thomson Locations: Queens , New York City, U.S, Cigna, Bengaluru, Washington, Los Angeles

They broke a record held by North Carolina, which had 23 consecutive double-digit wins over nonconference opponents in 2008 and 2009. UConn: The Huskies' nonconference schedule gets much tougher in the coming weeks with games against No. UConn shot 45.7% from the floor, but was just 4 of 28 from 3-point range (14.3%). UP NEXTNew Hampshire: The Wildcats continue a three-game swing through Connecticut with a game at Sacred Heart on Thursday. UConn: The Huskies travel to Lawrence, Kansas to take on the Jayhawks on Friday.

Persons: STORRS, —, “, ”, Dan Hurley, Donovan Clingan, Cam Spencer, Tristen Newton, Samson Johnson, Jaxson Baker, Ahmad Robinson, Clarence Daniels, Spencer, Baker, Clingan, Nathan Davis, Gonzaga, ” Clingan, ___ Organizations: New Hampshire, Huskies haven't, Big, New, New Mexico State, Huskies, Newtown, Connecticut, Rutgers, UConn, Wildcats, UConn outrebounded New, NEXT, Jayhawks, AP Locations: Conn, New, New Mexico, North Carolina, Lawrence , Kansas, New Hampshire, Connecticut, Hampshire, Kansas, Carolina, UConn outrebounded New Hampshire

☆ Jeremy Grantham's GMO just launched an actively managed fund focused on high-quality stocks. Its manager shares 7 unique companies he's betting on to deliver high returns.
▼ + stars: | 2023-11-24 | by ( William Edwards | ) www.businessinsider.com time to read: +4 min

The GMO US Quality ETF (QLTY) launched on November 12, and as its name implies, the fund seeks to offer investors exposure to so-called quality stocks through an actively managed approach. This story is available exclusively to Business Insider subscribers. "At GMO, internally we also talk about intrinsic value, which is adjusting for growth and quality," Hancock said. The aerospace business manufactures and re-services airplane engines, and the continued resurgence in global demand for travel following the pandemic bodes well for the business, Hancock said. While the timing of the ETF release is not related to Grantham's call, Hancock said quality stocks are typically more defensive in a recessionary environment.

Persons: Tom Hancock, Hancock, Jeremy Grantham, Grantham Organizations: Business, Microsoft, Apple, Nvidia, Electric, GE

Analysts attended earnings calls in the third quarter armed with questions for healthcare and consumer companies about the potential effect on their sales from the growing popularity of these drugs, known as GLP-1 agonists. A Reuters analysis of earnings transcripts for the third quarter showed "GLP-1" or alternatives like "obesity" or "weight-loss medications" were mentioned 256 times across 29 U.S. and European healthcare and consumer companies. That's more than double the mentions for the second quarter, when those phrases came up 127 times. While some consumer companies have talked about factors such as fewer calories being consumed, "these kind of large extrapolations" seem to be a bit of a stretch, said BMO Capital analyst Evan Seigerman. For big pharma manufacturers like Pfizer (PFE.N) and Amgen (AMGN.O), analyst questions were aimed at their obesity drug candidates.

Persons: Lilly, George Frey, Jeff Jonas, it's, Eli Lilly's, John Furner, Mondelez, Eli Lilly, Evan Seigerman, LVMH, Rajesh Kumar, Jonas, Bhanvi Satija, Savyata Mishra, Arpan Varghese, David Gaffen, Shounak Organizations: Novo Nordisk, Pharmacy, REUTERS, Gabelli, Novo, Walmart, Walmart U.S, Hershey, Truist Securities, Krispy, BMO Capital, Danish, pharma, Pfizer, Devices, HSBC, Thomson Locations: Provo , Utah, U.S, United States, Novo, Bengaluru

☆ These are the top 10 holdings of the Mormon Church's $47 billion stock portfolio
▼ + stars: | 2023-11-14 | by ( Matthew Fox | ) www.businessinsider.com time to read: +3 min

The investment arm of the Mormon Church revealed some of its holdings in a 13F filing on Tuesday. These are the top 10 holdings of the Mormon Church's stock portfolio as of September 30. AdvertisementThe Church of Jesus Christ of Latter-day Saints' has an investment portfolio topping $100 billion that includes $47 billion invested in stocks. AdvertisementThe church reports its stock holdings on a quarterly basis, and a recent 13F filing revealed its top holdings as of September 30. These are the Mormon Church's top 10 stocks holdings at the end of the third quarter.

Persons: —, of Jesus Christ, Tesla Brandon Bell, Ethan Miller, Microsoft Satya Nadella, Sean Gallup, Justin Sullivan Organizations: Mormon, Service, of Jesus, SEC, Advisors, Exxon Mobil, Mastercard Reuters, UnitedHealth, Reuters, Nvidia, Microsoft, Getty, Apple

☆ Humana shares fall as reaffirmed 2023 profit view disappoints
▼ + stars: | 2023-11-01 | by ( Khushi Mandowara | ) www.reuters.com time to read: +2 min

Signage for Humana Inc. is pictured at a health facility in Queens, New York City, U.S., November 30, 2021. The health insurer stuck to its 2023 adjusted profit target of at least $28.25 per share. As of Sept. 30, 5.9 million members were enrolled in its Medicare Advantage plans, up 14.7% from a year ago. The company raised its forecast for 2023 Medicare Advantage membership for the second time this year, and now expects to add at least 860,000 people. It reported a quarterly adjusted profit of $7.78 per share, beating analysts' estimate of $7.16 per share.

Persons: Andrew Kelly, Humana, Julie Utterback, Utterback, UnitedHealth, Khushi, Milla Nissi Organizations: Humana Inc, REUTERS, Wednesday, Health, Humana, Medicare, Thomson Locations: Queens , New York City, U.S, Bengaluru

☆ The sell-off in Humana is overdone after strong earnings. Jim Cramer says buy the stock
▼ + stars: | 2023-11-01 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +7 min

"The story is on track, and I think you buy the stock," Jim Cramer said during Wednesday's Morning Meeting . Since its 2023 lows on July 13, Humana stock rallied more than 23% compared with a roughly 7% slide in the S & P 500 over the same stretch. Management's initial commentary on 2024 earnings and Medicare Advantage membership growth — discussed in more detail below — may also have left investors wanting. Humana also expects EPS growth in 2024 to fall on the lower end of its historical long-range 11%-to-15% target. Capital allocation Humana still expects to buy back about $1.5 billion worth of stock in 2023, finance chief Diamond said on the earnings call.

Persons: —, Jim Cramer, they've, UnitedHealth, Humana, Susan Diamond, Diamond, Bruce Broussard, Jim Rechtin, Broussard, Jim Cramer's, Jim Organizations: Medicare, Revenue, Humana, UnitedHealth, CNBC, Inc

Despite a bleak month in October for the stock market, there may be some good news in store for at least four stocks in the Dow Jones Industrial Average . All three major market indexes are in the red this month, with the Dow off by 1.5% since the end of September. But investors may find some relief heading into the year end, since historically November has been a strong month for stocks. Analysts surveyed by LSEG have an average rating of hold on Caterpillar. Based on a consensus price target of $288, Caterpillar offers some 27% upside according to analyst estimates.

Persons: Dow, LSEG, Max, — CNBC's Christopher Hayes Organizations: Dow Jones, Stock, Dow, CNBC, Caterpillar, Analysts, LSEG, Boeing, Max . Insurance, UBS

☆ Our top 5 stocks of October so far as Wall Street rebounds from a September slump
▼ + stars: | 2023-10-17 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +6 min

After a rough September, October has so far been much more kind to stocks and has helped Wall Street cut into some of its third-quarter losses . FL mountain 2023-09-29 Foot Locker's stock performance so far in October. LLY mountain 2023-09-29 Eli Lilly's stock performance so far in October. PANW mountain 2023-09-29 Palo Alto's stock performance so far in October. HUM mountain 2023-09-29 Humana's stock performance so far in October.

Persons: Dow, Locker, Foot, Jim Cramer, Eli Lilly's, Eli Lilly, Jim Cramer's, Jim, Angela Weiss Organizations: Dow Jones, Nasdaq, Nike, Novo Nordisk, Palo Alto Networks, Nvidia, Johnson Controls, Palo Alto, Coterra Energy, Exxon Mobil, Club, Natural Resources, Humana, UnitedHealth, CNBC, New York Stock Exchange, Wall, AFP, Getty Locations: Alto, Israel, U.S, New York City

☆ UBS upgrades this 'core' health care stock, sees nearly 20% upside
▼ + stars: | 2023-10-16 | by ( Brian Evans | ) www.cnbc.com time to read: +1 min

UBS thinks UnitedHealth is an essential portfolio holding trading at a discount. The firm upgraded shares of the health care giant to buy from neutral and raised its target price to $640 from $520. "We believe that the strong Q3 release from UNH is a clearing event that should pave the way for improved valuation for the stock," Rice said. UnitedHealth stock has ticked up nearly 2% in 2023. UNH YTD mountain UNH in 2023 UNH YTD mountain UnitedHealth stock.

Persons: UnitedHealth, AJ Rice, Rice, — CNBC's Michael Bloom Organizations: UBS Locations: UNH

Search resuls for: "UNH"

25 mentions found